About microMend
microMend is a company based in Seattle (United States) founded in 2017. microMend has raised $3.41 million across 3 funding rounds. microMend offers products and services including microMend 2-in-1 Wound Repair Kit, microMend Laceration Kit with Large Devices, microMend Laceration Kit with Medium Devices, microMend Multi Pack with Medium Devices, and microMend Variety Pack. microMend operates in a competitive market with competitors including Kerecis, Kitotech Medical, PolyNovo, Contraline and Aroa Biosurgery, among others.
- Headquarter Seattle, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website micromendskinclosure.com
- Social LinkedIn X
- Legal Name Kitotech Medical, Inc.
- Total Equity Funding$3.41M (USD)
in 3 rounds
Products & Services of microMend
microMend offers a comprehensive portfolio of products and services, including microMend 2-in-1 Wound Repair Kit, microMend Laceration Kit with Large Devices, microMend Laceration Kit with Medium Devices, microMend Multi Pack with Medium Devices, and microMend Variety Pack.
Kit for fast, painless wound closure without sutures.
Device for closing larger wounds quickly and effectively.
Tool for medium wound closure with minimal scarring.
Multi-device pack for various wound sizes and applications.
Assortment of devices for diverse wound closure needs.
Funding Insights of microMend
microMend has successfully raised a total of $3.41M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.41M
- Total Rounds 3
- First Round $3M
(Aug 2020)
All 3 funding rounds of microMend with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | – | Series B | – | – | – |
| Nov 2020 | $407,000 | Seed | – | – | – |
| Aug 2020 | $3M | Seed | – | – | – |
Timeline of microMend
3 dated milestones of microMend across 4 years, from founding to its latest funding, stage changes and deals.
- Founded microMend is founded.
- Funding First funding round of $3.0M.
- Funding Latest funding round, Series B,.
Competitors of microMend
microMend operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kerecis, Kitotech Medical, PolyNovo, Contraline and Aroa Biosurgery, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kerecis.com | 2007 | Isafjordur, Iceland | $93.11M | 150 | Fish-skin acellular dermal matrix technology is provided for wound treatments. | |
| kitotechmedical.com | 2011 | Seattle, United States | $20.85M | – | Developer of a device to close wounds, lacerations, and surgical incisions | |
| polynovo.com | 2004 | Port Melbourne, Australia | – | – | Developer of biodegradable temporising matrix for treating traumatic wounds | |
| contraline.com | 2015 | Charlottesville, United States | $18.62M | 7 | Contraline is focused on developing innovative male contraception solutions. | |
| aroa.com | 2008 | Mangere, New Zealand | – | – | Developer of medical and surgical products for soft tissue reconstruction | |
| acell.com | 1999 | Lafayette, United States | $8.7M | 398 | Regenerative products for tissue repair are developed using ECM technology. | |
| resivantmedical.com | 2018 | Akron, United States | $1.08M | – | Surgical adhesives for topical skin closure are developed. | |
| curiato.com | 2014 | Waterloo, Canada | $30,000 | 15 | Developer of pressure redistribution mattress and ulcer management platform | |
| z-medica.com | 2002 | Wallingford, United States | – | 124 | Hemostatic products for bleeding control are provided by Z-Medica. |
Detailed competitors of microMend
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of microMend
The website of microMend (micromendskinclosure.com) receives about 4.6K visits a month.
- Monthly visits4.6K
▲ 96.2% vs previous month
Latest news on Micromend
Complete news archive for microMend
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to microMend
10 companies that operate in the same segment as microMend (Wound Care), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Fish-skin acellular dermal matrix technology is provided for wound treatments. | 2007 | Isafjordur, Iceland | USD 93.11 M | – | 150 | |
Developer of advanced haemostat and wound care dressing products | 2008 | Ahmedabad, Gujarat, India | USD 42.71 M | USD 2.88 M | 70 | |
Oxygen-based wound therapy devices are developed for healing non-healing wounds. | 2003 | Waterbeach, Cambridgeshire, United Kingdom | USD 68.39 M | – | – | |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | – | USD 418.63 M | 837 | |
Biological drugs for skin and mucosa wound treatment are developed. | 2016 | Uppsala, Uppsala County, Sweden | USD 4.02 M | USD 1.12 M | – | |
Developer of hemostatic products for wound care | 2010 | New York, New York, United States | USD 113.35 M | – | – | |
Regenerative therapies for wound care are developed and commercialized. | 1985 | Canton, Ohio, United States | USD 30 M | USD 564.17 M | 869 | |
Cold plasma solutions for wound treatment are developed. | 2013 | Eindhoven, Noord-brabant, Netherlands | USD 7.06 M | – | – | |
Point-of-care devices for wound bacterial assessment are provided. | 2013 | Toronto, Ontario, Canada | USD 43.2 M | – | 49 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about microMend
microMend was founded in 2017 and raised its 1st funding round 3 years after it was founded.
microMend is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
microMend is a funded company, having raised a total of $3.41M across 3 funding rounds to date. The company's 1st funding round was a Seed of $3M, raised on Aug 2020.
MicroMend was founded in 2017 and is based in Seattle, United States. Operations focus on the medical device sector, specifically solutions for dermatological treatments. A wound closure device is developed that applies tiny staples to the skin edges of wounds, functioning similarly to a butterfly bandage. This approach is designed to be painless and to facilitate wound healing up to three times faster than with sutures.
microMend's top competitors include Kerecis, Kitotech Medical and PolyNovo.
microMend offers microMend 2-in-1 Wound Repair Kit, microMend Laceration Kit with Large Devices, microMend Laceration Kit with Medium Devices, microMend Multi Pack with Medium Devices, and microMend Variety Pack.
microMend operates through Kitotech Medical, Inc..